|
1
|
A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
|
N Engl J Med
|
2002
|
5.58
|
|
2
|
A single cycle of rituximab for the treatment of severe pemphigus.
|
N Engl J Med
|
2007
|
2.41
|
|
3
|
B-cell depletion immunotherapy in pemphigus: effects on cellular and humoral immune responses.
|
J Invest Dermatol
|
2008
|
2.10
|
|
4
|
Prospective multicenter study of pegylated liposomal doxorubicin treatment in patients with advanced or refractory mycosis fungoides or Sézary syndrome.
|
Arch Dermatol
|
2008
|
1.47
|
|
5
|
A comparison of two regimens of topical corticosteroids in the treatment of patients with bullous pemphigoid: a multicenter randomized study.
|
J Invest Dermatol
|
2009
|
1.26
|
|
6
|
Risk factors for bullous pemphigoid in the elderly: a prospective case-control study.
|
J Invest Dermatol
|
2010
|
1.22
|
|
7
|
Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response.
|
Sci Transl Med
|
2013
|
1.15
|
|
8
|
Comparison of topical methyl aminolevulinate photodynamic therapy with cryotherapy or Fluorouracil for treatment of squamous cell carcinoma in situ: Results of a multicenter randomized trial.
|
Arch Dermatol
|
2006
|
1.07
|
|
9
|
Ipilimumab in melanoma patients with brain metastasis: a retro-spective multicentre evaluation of thirty-eight patients.
|
Acta Derm Venereol
|
2014
|
0.91
|
|
10
|
Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid.
|
JAMA Dermatol
|
2013
|
0.86
|
|
11
|
Cutaneous malignant melanoma and neurofibromatosis type 1.
|
Melanoma Res
|
2004
|
0.85
|
|
12
|
Assessment of the rate of long-term complete remission off therapy in patients with pemphigus treated with different regimens including medium- and high-dose corticosteroids.
|
J Am Acad Dermatol
|
2013
|
0.84
|
|
13
|
Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis.
|
Arthritis Rheum
|
2008
|
0.82
|
|
14
|
Temozolomide associated with PEG-interferon in patients with metastatic melanoma: a multicenter prospective phase I/II study.
|
Melanoma Res
|
2008
|
0.82
|
|
15
|
Generalized eczema craquele as a presenting feature of systemic lymphoma: report of seven cases.
|
Acta Derm Venereol
|
2005
|
0.82
|
|
16
|
Temozolomide and cisplatin combination in naive patients with metastatic cutaneous melanoma: results of a phase II multicenter trial.
|
Melanoma Res
|
2010
|
0.82
|
|
17
|
Blue light is phototoxic for B16F10 murine melanoma and bovine endothelial cell lines by direct cytocidal effect.
|
Anticancer Res
|
2010
|
0.81
|
|
18
|
Solar urticaria treated with intravenous immunoglobulins.
|
J Am Acad Dermatol
|
2011
|
0.79
|
|
19
|
Efalizumab-induced lupus-like syndrome.
|
Acta Derm Venereol
|
2008
|
0.75
|
|
20
|
The France-PDT study: a national prospective observational cohort survey on the use of methyl-aminolevulinate photodynamic therapy in France, with up to 6-month follow-up.
|
Eur J Dermatol
|
2013
|
0.75
|
|
21
|
Tumoral macroglobulinosis of the skin: In situ release of IgM.
|
Acta Derm Venereol
|
2006
|
0.75
|
|
22
|
No major effect of cyclosporin A in patients with severe solar urticaria: a french retrospective case series.
|
Acta Derm Venereol
|
2015
|
0.75
|
|
23
|
Sentinel Node Status and Immunosuppression: Recurrence Factors in Localized Merkel Cell Carcinoma.
|
Acta Derm Venereol
|
2015
|
0.75
|